Effect of the Timing of Antiretroviral Treatment Initiation on Outcomes in Children Living With Human Immunodeficiency Virus Admitted With Severe Acute Malnutrition

Overview

Journal J Pediatric Infect Dis Soc

Publisher Oxford University Press

Specialties Infectious Diseases
Pediatrics

Date 2020 May 30

PMID 32469406

Citations 3

Authors

Moherndran Archary

Benn Sartorius

Philip La Russa

Thobekile Sibaya

Micheal Healy

Raziya A Bobat

Affiliations

Soon will be listed here.

Abstract

Background: Delays in early infant diagnosis and antiretroviral treatment (ART) initiation in developing countries frequently result in malnutrition at initial presentation with associated higher mortality and delayed immune recovery. The optimal timing of ART initiation is yet to be established.

Methods: Eighty-two children admitted with HIV and severe acute malnutrition (SAM) between July 2012 and December 2015 were enrolled. Patients were randomized to initiate ART within 14 days from admission (early arm) or delay ART initiation until nutritional recovery and >14 days after admission (delayed arm). All patients received a standardized treatment and feeding protocol and were followed to 48 weeks.

Results: The mean age of the patients at baseline was 23.3 months (standard deviation [SD], 27.9; range, 1.6-129 months). The mean time from admission to ART initiation was 5.6 days (SD, 4.4) in the early arm and 23 days (SD, 5.8) in the delayed arm (P < .001). There was no significant difference in mortality (P = .62), virologic response (P = .53), and anthropometric response (P = .57) between the 2 groups at 48 weeks. However, the rates of change in CD4, viral load, weight for age z score, and height for age z score occurred earlier and favored the delayed arm at early time points but were not significant at 24 and 48 months.

Conclusions: Despite initial improved responses in the delayed arm, lack of difference in outcome at 48 weeks supports a pragmatic approach with earlier ART initiation in children living with HIV admitted with SAM.In this randomised controlled study of ART initiation in children admitted with HIV and severe acute malnutrition (SAM), despite initial improved responses in the delayed arm, lack of difference in outcome at 48 weeks supports a pragmatic approach with earlier ART initiation in children living with HIV admitted with SAM.

Clinical Trials Registration: PACTR 21609001751384.

Citing Articles

Survival status and predictors of mortality among severely acute malnourished under-5 children admitted to stabilisation centers in selected government hospitals in Addis Ababa, Ethiopia, 2022: a retrospective cohort study.

Abdu A, Murugan R, Tilahun S BMJ Open. 2024; 14(8):e083855.

PMID: 39107018 PMC: 11308885. DOI: 10.1136/bmjopen-2023-083855.

Early Initiation of Antiretroviral Therapy is Protective Against Seizures in Children With HIV in Zambia: A Prospective Case-Control Study.

Bearden D, Mwanza-Kabaghe S, Bositis C, Dallah I, Johnson B, Siddiqi O J Acquir Immune Defic Syndr. 2023; 95(3):291-296.

PMID: 38032746 PMC: 10922319. DOI: 10.1097/QAI.0000000000003357.

The hard part we often forget: providing care to children and adolescents with advanced HIV disease.

Frigati L, Gibb D, Harwell J, Kose J, Musiime V, Rabie H J Int AIDS Soc. 2023; 26(3):e26041.

PMID: 36943761 PMC: 10029994. DOI: 10.1002/jia2.26041.

References

Smith K, Kuhn L, Coovadia A, Meyers T, Hu C, Reitz C . Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS. 2009; 23(9):1097-107. PMC: 2810152. DOI: 10.1097/QAD.0b013e32832afefc. View

French M . HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis. 2008; 48(1):101-7. DOI: 10.1086/595006. View

Hakim J, Musiime V, Szubert A, Mallewa J, Siika A, Agutu C . Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa. N Engl J Med. 2017; 377(3):233-245. PMC: 5603269. DOI: 10.1056/NEJMoa1615822. View

Njuguna I, Cranmer L, Otieno V, Mugo C, Okinyi H, Benki-Nugent S . Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial. Lancet HIV. 2017; 5(1):e12-e22. PMC: 5777310. DOI: 10.1016/S2352-3018(17)30167-4. View

Oshikoya K, Sammons H, Choonara I . A systematic review of pharmacokinetics studies in children with protein-energy malnutrition. Eur J Clin Pharmacol. 2010; 66(10):1025-35. DOI: 10.1007/s00228-010-0851-0. View

Fergusson P, Tomkins A . HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2008; 103(6):541-8. DOI: 10.1016/j.trstmh.2008.10.029. View

Orikiiriza J, Bakeera-Kitaka S, Musiime V, Mworozi E, Mugyenyi P, Boulware D . The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS. 2010; 24(13):2009-17. PMC: 2914829. DOI: 10.1097/QAD.0b013e32833b260a. View

Callens S, Shabani N, Lusiama J, Lelo P, Kitetele F, Colebunders R . Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J. 2008; 28(1):35-40. DOI: 10.1097/INF.0b013e318184eeb9. View

Verweel G, van Rossum A, Hartwig N, Wolfs T, Scherpbier H, de Groot R . Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics. 2002; 109(2):E25. DOI: 10.1542/peds.109.2.e25. View

10.

Krishnaswamy K, Ushasri V, Naidu N . The effect of malnutrition on the pharmacokinetics of phenylbutazone. Clin Pharmacokinet. 1981; 6(2):152-9. DOI: 10.2165/00003088-198106020-00005. View

11.

Heikens G, Bunn J, Amadi B, Manary M, Chhagan M, Berkley J . Case management of HIV-infected severely malnourished children: challenges in the area of highest prevalence. Lancet. 2008; 371(9620):1305-7. DOI: 10.1016/S0140-6736(08)60565-6. View

12.

Murdoch D, Venter W, Van Rie A, Feldman C . Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther. 2007; 4:9. PMC: 1871602. DOI: 10.1186/1742-6405-4-9. View

13.

Rose A, Hall C, Martinez-Alier N . Aetiology and management of malnutrition in HIV-positive children. Arch Dis Child. 2014; 99(6):546-51. PMC: 4033118. DOI: 10.1136/archdischild-2012-303348. View

14.

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

15.

Kurawige J, Gatsinzi T, Kleinfeldt V, Rehle T, Bulterys M . HIV-1 infection among malnourished children in Butare, Rwanda. J Trop Pediatr. 1993; 39(2):93-6. DOI: 10.1093/tropej/39.2.93. View

16.

Taye B, Shiferaw S, Enquselassie F . The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART). Ethiop Med J. 2010; 48(1):1-10. View

17.

Kim M, Cox C, Dave A, Draper H, Kabue M, Schutze G . Prompt initiation of ART With therapeutic food is associated with improved outcomes in HIV-infected Malawian children with malnutrition. J Acquir Immune Defic Syndr. 2011; 59(2):173-6. DOI: 10.1097/QAI.0b013e3182405f8f. View

18.

Marazzi M, DE Luca S, Palombi L, Scarcella P, Ciccacci F, Ceffa S . Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa. Pediatr Infect Dis J. 2013; 33(3):295-300. DOI: 10.1097/INF.0b013e3182a0994b. View

19.

Ruel T, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal P . Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2013; 65(5):535-41. PMC: 3999287. DOI: 10.1097/QAI.0000000000000071. View

20.

Argemi X, Dara S, You S, Mattei J, Courpotin C, Simon B . Impact of malnutrition and social determinants on survival of HIV-infected adults starting antiretroviral therapy in resource-limited settings. AIDS. 2012; 26(9):1161-6. DOI: 10.1097/QAD.0b013e328353f363. View